Provided by Tiger Trade Technology Pte. Ltd.

Haemonetics

107.60
+1.361.28%
Pre-market: 108.040.4400+0.41%07:22 EDT
Volume:621.12K
Turnover:67.37M
Market Cap:4.89B
PE:52.49
High:109.83
Open:108.39
Low:107.56
Close:106.24
52wk High:109.83
52wk Low:47.32
Shares:45.45M
Float Shares:44.60M
Volume Ratio:1.07
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.05
EPS(LYR):2.05
ROE:11.20%
ROA:6.60%
PB:5.84
PE(LYR):52.49

Loading ...

Aug 18, 2026

Major Issues Report

Form 8-K - Current report
Aug 12, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 06, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2026

Major Issues Report

Form 8-K - Current report
Jul 29, 2026

Major Issues Report

Form 8-K - Current report
Jun 05, 2026

Major Issues Report

Form 8-K - Current report
May 20, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
May 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 07, 2026

Major Issues Report

Form 8-K - Current report
May 01, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 29, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Mar 03, 2026

Major Issues Report

Form 8-K - Current report
Feb 13, 2026

Major Issues Report

Form 8-K - Current report
Feb 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 05, 2026

Major Issues Report

Form 8-K - Current report
Jan 09, 2026

Major Issues Report

Form 8-K - Current report
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]